Logotype for Tata Chemicals Limited

Tata Chemicals (TATACHEM) Q2 25/26 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Tata Chemicals Limited

Q2 25/26 earnings summary

3 Nov, 2025

Executive summary

  • Global demand for key products remains flat in the near term, with robust demand in India and Asia (excluding China), but weakness in China and Southeast Asia due to oversupply and high inventories.

  • Medium- to long-term outlook is positive, driven by solar PV and EV growth, despite short-term margin challenges and ongoing geopolitical and tariff risks.

  • Board approved unaudited consolidated and audited standalone financial results for Q2 and H1 FY2026, with results published and available online.

  • Board approved fund raising via non-convertible debentures (NCDs) up to ₹1,500 crore on a private placement basis.

  • Higher sales volumes in India were offset by lower realizations across all geographies, impacting profitability.

Financial highlights

  • Standalone revenue from operations increased 19% year-over-year; EBITDA rose 67%; profit after tax up 80%.

  • Consolidated revenue for Q2 FY2026 was ₹3,877 crore, down from ₹3,999 crore in Q2 FY2025; H1 FY2026 revenue was ₹7,596 crore, down from ₹7,788 crore in H1 FY2025.

  • Q2 FY2026 EBITDA margin was 14%, down from 15% in Q2 FY25; PAT margin was 6%, compared to 7% in Q2 FY25.

  • Net profit for Q2 FY2026 stood at ₹154 crore, compared to ₹267 crore in Q2 FY2025.

  • Net debt increased to ₹5,583 crore as of Sep 2025 from ₹4,884 crore in Mar 2025.

Outlook and guidance

  • Soda ash prices expected to remain subdued and range-bound for the rest of the year due to oversupply and high Chinese inventories.

  • U.K. operations expected to turn positive in Q3 and Q4 as reconfiguration completes and focus shifts to value-added products.

  • Indian margins expected to stabilize, with volumes tracking higher and anti-dumping measures providing some price support.

  • Medium-term market normalization anticipated as global capacity reconfiguration progresses and tariff frictions ease.

  • Board authorized an internal committee to finalize terms for the NCD issuance, indicating a focus on strengthening liquidity and funding future growth.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more